期刊文献+

小鼠皮下移植性肝癌模型的热消融研究 被引量:3

Thermal ablation for subcutaneously implanted hepatocellular carcinoma in mice
原文传递
导出
摘要 目的:探讨建立适合微波消融研究的肝癌小鼠模型。方法:将C57BL/6J小鼠随机分为4组(n=10),分别皮下注射不同数量(5×10^5,1×10^6,2×10^6,5×10^6)的Hepal-6细胞,比较各组成瘤率;选择成瘤率理想的细胞数再次造模,待瘤体长径达8-10mm时将模型小鼠随机分为4组(n=10),对瘤体行微波热消融处理,瘤体边缘温度分别控制在60℃,55℃,50℃和45℃,消融时间为3min,比较各组完全消融率及消融前后的瘤体病理变化。结果:2×1×10^6的Hepal-6细胞皮下注射组成瘤率高且适合消融操作;60℃消融组出现组织碳化,其余各组比较,55℃消融组完全消融率最高,复发率最低(P〈0.01)。结论:对小鼠Hepal-6细胞皮下移植性肝癌模型行55℃×3min的微波热消融有效、可行。 Objective: To establish a mice model of liver cancer suitable for microwave ablation. Methods: C57BL/6J mice were randomly divided into 4 groups (n=10 in each group) and subcutaneously injected with Hepal-6 cells of different numbers (5×10^6, 1×10^6, 2×10^6 and 5×10^6) respectively, and then the tartor formation rates in the 4 groups were compared. Next, the ideal cell number for tumor formation was selected to establish the mouse models once again. When mean tumor diameter reached 8-10 mm, the tumor-bearing mice were randomly divided into 4 groups (n=10 in each group) to undergo microwave thermal tumor ablation. The temperature at the edge of the tumor was maintained at 60, 55, 50, and 45 % respectively, and the ablation time was 3 min. The complete ablation rate and pathological changes of tumor among the 4 groups were compared.Results: The group with 2×10^6 Hepal-6 subcutaneous injection had a high tumor formation rate and was suitable for ablation. Except for 60% ablation group, in other 3 groups, the 55℃ablation group had the highest complete ablation rate and the lowest recurrence compared with the other two groups (P〈0.05). Conclusion: 55℃ × 3 min microwave ablation is feasible and effective for Hepal-6 cells subcutaneously implanted model of liver cancer in mice.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第8期973-977,共5页 China Journal of General Surgery
基金 国家自然科学基金资助项目(81071892) 广州市医药卫生科技项目(20121A010012) 高等高校博士学科点专科专项科研基金(新教师类 201000171120072) 高校基本科研业务费中山大学青年教师培育项目(09ykpy30)
关键词 肝肿瘤 实验性 热消融 疾病模型 动物 小鼠 Liver Neoplasms, Experimental Thermal Ablation Disease Models, Animal Mice
  • 相关文献

参考文献9

二级参考文献43

  • 1Juan Zhang~1 Jin-Kun Zhang~2 Shao-Hong Zhuo~3 Hai-Bin Chen~2 1 Clinical Laboratory,The First Affiliated Hospital of Shantou University Medical College,Shantou 515041,Guangdong Province,China2 Cancer Pathology Laboratory,Shantou University Medical College,Shantou 515031,Guangdong Province,China3 Department of Gastroenterology,Third Municipal Hospital of Shantou,Shantou 515073,Guangdong Province,China.Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells[J].World Journal of Gastroenterology,2001,7(5):690-694. 被引量:26
  • 2Bao-GangPeng Li-JiangLiang QiangHe MingKuang Jia-MingLia Ming-DeLu Jie-FuHuang.Tumor vaccine against recurrence of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(5):700-704. 被引量:28
  • 3陈孝平,张万广.肝细胞性肝癌实验研究的热点与展望[J].中华实验外科杂志,2006,23(3):264-265. 被引量:19
  • 4谭进富,吕明德,刘大全,王竹,周忠信,黄洁夫.微波消融肝癌对小鼠细胞免疫的影响[J].中国病理生理杂志,2006,22(6):1214-1217. 被引量:10
  • 5彭宝岗,梁力建,何强,匡铭,黄洁夫,吕明德.细胞因子缓释微球的肿瘤疫苗治疗肝癌的实验研究[J].中国病理生理杂志,2006,22(6):1235-1237. 被引量:3
  • 6郭峰.红细胞增强淋巴细胞与粒细胞粘附肿瘤细胞的作用[J].第二军医大学学报,1989,10(6):558-558.
  • 7Lu MD,Chen JW,Xie XY,et al.Hepatocellular carcinoma:US-guided percutaneous microwave coagulation therapy.Radiology,2001,221:167-172.
  • 8Peng BG,Liu SQ,Kuang M,et al.Autologous fixed tumor vaccine:a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma.Jpn J Cancer Res,2002,93:363-368.
  • 9Nakao M, Sata M, Saitsu H, et al. CD4^+ hepatic cancerspecific cytotoxic T lymphocytes in patients with hepatocellular carcinoma [ J ] . Cell Immunol , 1997 , 177 ( 2 ) : 176 - 181 .
  • 10Chavan SS, Chiplunkar SV. Immunophenotypes and cytotoxic functions of lymphocytes in patients withhepatocellular carcinoma[J]. Tumori,1997, 83(4) :762 -767.

共引文献103

同被引文献41

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部